Antipsychotic Medication and Diabetes Mellitusrs
J Clin Psychiatry 2005;66(3):395[letter]
© Copyright 2017 Physicians Postgraduate Press, Inc.
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Spoelstra and colleagues1
assert that antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus and speculate from their pharmacoepidemiologic study that this worsening is probably due to β-cell toxicity. While there is general agreement that exposure to antipsychotic medications (and second-generation agents in particular) may be associated with an increased risk of diabetes mellitus,2
there are several problems regarding the authors’ interpretation of the data. First, a comparison group of those not taking antipsychotics is probably not comparable to a group taking these medications.